Navamedic ASA - Asset Resilience Ratio
Navamedic ASA (NAVA) has an Asset Resilience Ratio of 11.25% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Navamedic ASA carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2025)
This chart shows how Navamedic ASA's Asset Resilience Ratio has changed over time. See NAVA total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Navamedic ASA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Navamedic ASA (NAVA) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr74.16 Million | 10.0% |
| Short-term Investments | Nkr9.30 Million | 1.25% |
| Total Liquid Assets | Nkr83.45 Million | 11.25% |
Asset Resilience Insights
- Moderate Liquidity: Navamedic ASA has 11.25% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Navamedic ASA Industry Peers by Asset Resilience Ratio
Compare Navamedic ASA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.44% |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332 |
Medical Distribution | 5.56% |
Annual Asset Resilience Ratio for Navamedic ASA (2008–2025)
The table below shows the annual Asset Resilience Ratio data for Navamedic ASA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 11.25% | Nkr83.45 Million ≈ $8.78 Million |
Nkr741.75 Million ≈ $78.05 Million |
+0.61pp |
| 2024-12-31 | 10.64% | Nkr52.27 Million ≈ $5.50 Million |
Nkr491.24 Million ≈ $51.69 Million |
+3.34pp |
| 2023-12-31 | 7.30% | Nkr38.29 Million ≈ $4.03 Million |
Nkr524.30 Million ≈ $55.17 Million |
-9.78pp |
| 2022-12-31 | 17.08% | Nkr65.39 Million ≈ $6.88 Million |
Nkr382.77 Million ≈ $40.28 Million |
+1.15pp |
| 2021-12-31 | 15.94% | Nkr52.62 Million ≈ $5.54 Million |
Nkr330.18 Million ≈ $34.74 Million |
+14.11pp |
| 2020-12-31 | 1.83% | Nkr4.76 Million ≈ $501.20K |
Nkr260.04 Million ≈ $27.36 Million |
+9.38pp |
| 2019-12-31 | -7.55% | Nkr-14.13 Million ≈ $-1.49 Million |
Nkr187.06 Million ≈ $19.68 Million |
-12.70pp |
| 2018-12-31 | 5.14% | Nkr11.05 Million ≈ $1.16 Million |
Nkr214.73 Million ≈ $22.60 Million |
-7.09pp |
| 2017-12-31 | 12.23% | Nkr30.25 Million ≈ $3.18 Million |
Nkr247.27 Million ≈ $26.02 Million |
+2.92pp |
| 2016-12-31 | 9.32% | Nkr26.80 Million ≈ $2.82 Million |
Nkr287.67 Million ≈ $30.27 Million |
-54.54pp |
| 2008-12-31 | 63.86% | Nkr101.95 Million ≈ $10.73 Million |
Nkr159.65 Million ≈ $16.80 Million |
-- |
About Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutritio… Read more